Equinox Family Medicine, Pc | |
3869 Main St. Manchester VT 05254 | |
(802) 362-1121 | |
(802) 362-9121 |
Full Name | Equinox Family Medicine, Pc |
---|---|
Speciality | Nurse Practitioner - Primary Care |
Location | 3869 Main St., Manchester, Vermont |
Authorized Official Name and Position | Mara V Liebling (OWNER) |
Authorized Official Contact | 8023621121 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Equinox Family Medicine, Pc Po Box 50 3869 Main St. Manchester VT 05254-0050 Ph: (802) 362-1121 | Equinox Family Medicine, Pc 3869 Main St. Manchester VT 05254 Ph: (802) 362-1121 |
NPI Number | 1447378575 |
---|---|
Provider Enumeration Date | 03/27/2007 |
Last Update Date | 08/22/2020 |
Identifier | Type | State | Issuer |
---|---|---|---|
1447378575 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | (* (Not Available)) | Primary |
363LP2300X | Nurse Practitioner - Primary Care | (* (Not Available)) | Primary |
News Archive
Thanks to rising obesity rates in Latin America and the Caribbean, elderly people there are becoming more likely to suffer from disabilities, according to a paper recently published by University of Texas Medical Branch at Galveston researchers in the American Journal of Epidemiology.
The pelvic exam, a standard part of a woman's gynecologic checkup, frequently is performed for reasons that are medically unjustified, according to the authors of a UCSF study that may lay the groundwork for future changes to medical practice.
The finding also reveals how the retina's own stem cells can be directed to aid the growth of new cells to replace diseased or dying ones in the eye. Study results appear in the June 24 issue of the journal Science.
MannKind Corporation announced that it was informed today by the Food and Drug Administration that the FDA will not be able to complete the review of MannKind's new drug application (NDA) for its ultra rapid-acting insulin therapy by the action date of January 16, 2010.
› Verified 7 days ago